1 证券代码：300607 证券简称：拓斯达 债券代码：123101 债券简称：拓斯转债 广东拓斯达科技股份有限公司 投资者关系活动记录表 编号：2022005 | --- | --- | --- | |-------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------| | 投资者关系 \n活动类别 | □特定对象调研 □分析师会议 ...

编号：2022008 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 投资者关系 □新闻发布会 □路演活动 活动类别 现场参观 电话/网络会议 参与单位名称及 1 证券代码：300607 证券简称：拓斯达 债券代码：123101 债券简称：拓斯转债 广东拓斯达科技股份有限公司 投资者关系活动记录表 国金证券股份有限公司、中国人寿资产管理有限公司、生命保 险资产管理有限公司 | --- | --- | --- | |--------------|------------------------------|------------------------------------------------| | 人员姓名 | | | | 时间 | 2022 年 7 月 16 日 | 9:00~12:00 | | 地点 | 公司会议室 | | | 上市公司 | | 副总裁、董事会秘书孔天舒；投资者关系总监谢仕梅 | | 接待人员姓名 | | | | --- | --- | |-----------------------------|-------------------------------------- ...

1 证券代码：300607 证券简称：拓斯达 债券代码：123101 债券简称：拓斯转债 广东拓斯达科技股份有限公司 投资者关系活动记录表 编号：2022009 | --- | --- | --- | --- | --- | --- | --- | |-------------------------|-------------------------------------------------------------|-------------|-------|-------|-------|-------| | | | | | | | | | | □特定对象调研 □分析师会议 | | | | | | | | □媒体采访 □业绩说明会 | | | | | | | 投资者关系 | □新闻发布会 | □路演活动 | | | | | | 活动类别 | 现场参观 | | | | | | | | 电话/网络会议 | | | | | | | 参与单位名称及 人员姓名 | 广发证券、鹏华基金、开源证券、通用技术集团投资管理有限 公司 | | | | | | | 时间 | 2022 年 7 月 20 日 | 13:00 ...

证券代码：300607 证券简称：拓斯达 债券代码：123101 债券简称：拓斯转债 广东拓斯达科技股份有限公司 投资者关系活动记录表 编号：2022007 | --- | --- | --- | --- | --- | --- | |----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 | | | | | | 投资者关系 | □新闻发布会 □路 ...

1 证券代码：300607 证券简称：拓斯达 债券代码：123101 债券简称：拓斯转债 广东拓斯达科技股份有限公司 投资者关系活动记录表 编号：2022006 | --- | --- | --- | --- | |----------------|-----------------------------------------------|----------|-------| | | | | | | | | | | | | □特定对象调研 □分析师会议 | | | | | □媒体采访 □业绩说明会 | | | | 投资者关系 | □新闻发布会 | 路演活动 | | | 活动类别 | 现场参观 | | | | | 电话 / 网络会议 | | | | | 富国基金 | | | | 参与单位名称及 | 固信控股 | | | | 人员姓名 | 光大证券 | | | | | 光证金控 | | | | | 广发基金 | | | | | 国金证券 | | | | | 国信证券投资部 | | | | | 海富通基金 合煦智远基金 | | | | | Hel Ved Capital 华宝信托有限责任公司 华夏基金 | | ...

证券代码：300607 证券简称：拓斯达 债券代码：123101 债券简称：拓斯转债 编号：2022011 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 投资者关系 □新闻发布会 □路演活动 活动类别 现场参观 电话/网络会议 1 广东拓斯达科技股份有限公司 投资者关系活动记录表 | --- | --- | |-------------------------|---------------------------------------------------------------------| | | | | 参与单位名称及 人员姓名 | 南方基金、华泰证券 | | 时间 | 2022 年 9 月 14 日 14:00-16:00 | | 地点 | 公司会议室 | | 上市公司 接待人员姓名 | 董事长、总裁吴丰礼；副总裁、董事会秘书孔天舒；投资者关 系总监谢仕梅 | | --- | --- | |-----------------------------|--------------------------------------------------------------------- ...

证券代码：300607 证券简称：拓斯达 债券代码：123101 债券简称：拓斯转债 广东拓斯达科技股份有限公司 投资者关系活动记录表 编号： | --- | --- | --- | --- | --- | |-------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------|-------|---------| | | | | | 2022012 | | | □特定对象调研 □分析师会议 | | | | | 投资者关系 | □媒体采访 □业绩说明会 | | | | | 活动类别 | ...

证券代码：300607 证券简称：拓斯达 债券代码：123101 债券简称：拓斯转债 1 广东拓斯达科技股份有限公司 投资者关系活动记录表 编号：2022013 | --- | --- | --- | --- | |-------------------------|--------------------------------------------------------------------------------------------|-------------------------------------|-------| | | □特定对象调研 □分析师会议 | | | | | □媒体采访 | 业绩说明会 | | | 投资者关系 | □新闻发布会 | □路演活动 | | | 活动类别 | 现场参观 | | | | | 电话 / 网络会议 | | | | 参与单位名称及 人员姓名 | Goldman Sachs Artisan Partners Asset Management Inc Polymer Capital Mgmt (HK) Ltd | | | | | UOB Private B ...

Financial Performance - The company's revenue for Q3 2022 reached ¥1,246,076,995.29, representing a 69.54% increase year-over-year[4] - Net profit attributable to shareholders was ¥37,711,855.78, a significant increase of 750.10% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥31,205,003.71, up 1,736.39% year-over-year[4] - Total operating revenue for Q3 2022 reached CNY 3,288,785,205.43, a significant increase of 43.7% compared to CNY 2,289,243,151.77 in the same period last year[19] - Net profit for Q3 2022 was CNY 140,976,830.52, representing an increase of 6.1% from CNY 132,296,084.72 in Q3 2021[20] - Earnings per share (EPS) for Q3 2022 was CNY 0.33, compared to CNY 0.31 in the same quarter last year, reflecting a growth of 6.5%[21] - The company reported a comprehensive income total of CNY 166,832,030.67 for Q3 2022, compared to CNY 130,926,413.93 in the same period last year, reflecting a growth of 27.4%[21] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥6,658,019,127.95, reflecting a 6.03% increase from the end of the previous year[4] - Total assets increased from ¥6,279,256,653.39 to ¥6,658,019,127.95, reflecting a growth of about 6.0%[16] - The total liabilities increased to CNY 4,268,654,268.32 from CNY 4,015,702,754.05, indicating a rise of 6.3% year-on-year[20] - The total equity attributable to shareholders of the parent company rose to CNY 2,334,038,206.47, up from CNY 2,210,298,494.77, marking an increase of 5.6%[20] Cash Flow - The company reported a net cash flow from operating activities of ¥75,290,755.65, a 112.28% increase compared to the previous year[9] - Cash flow from operating activities generated a net amount of CNY 75,290,755.65, a turnaround from a negative cash flow of CNY -613,320,355.17 in the previous year[22] - Investment activities generated a net cash flow of -121,934,623.93 CNY in Q3 2022, compared to -155,191,824.28 CNY in Q3 2021[23] - Financing activities resulted in a net cash flow of -159,732,946.18 CNY in Q3 2022, contrasting with a positive net cash flow of 620,175,266.81 CNY in Q3 2021[23] - Total cash and cash equivalents at the end of Q3 2022 amounted to 791,817,605.38 CNY, down from 810,035,801.71 CNY in Q3 2021[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 35,105[11] - The company repurchased 2,128,700 shares, accounting for 0.50% of the total share capital as of September 30, 2022[12] - The number of shares held by the top shareholder, Wu Fengli, is 144,629,860, representing 33.93% of total shares[11] - The company has a total of 140,869,305 restricted shares at the end of the reporting period[14] - The total number of non-restricted shares held by Wu Fengli is 36,157,465[11] Operational Metrics - The company's gross profit margin improved, with operating income increasing by 43.66% to ¥3,288,785,205.43[8] - Total operating costs amounted to CNY 3,036,443,311.96, up 43.7% from CNY 2,110,590,349.24 year-on-year, with operating costs specifically rising from CNY 1,691,286,555.67 to CNY 2,618,848,253.95[20] - Research and development expenses for Q3 2022 were CNY 83,552,430.01, down from CNY 91,574,144.10 in Q3 2021, indicating a decrease of 8.8%[20] Investment and Financial Activities - The company experienced a 3807.05% increase in investment income, amounting to ¥5,866,079.87, attributed to the maturity of financial products[8] - The company received tax refunds amounting to CNY 59,130,451.64, a significant increase from CNY 6,821,587.71 in the previous year[22] - Cash inflow from investment activities totaled 776,646,196.90 CNY, while cash outflow was 898,580,820.83 CNY in Q3 2022[23] - The company received 613,372,000.00 CNY in cash from borrowings during Q3 2022, compared to 179,000,000.00 CNY in Q3 2021[23] Other Financial Information - The financial expenses surged by 338.18% to ¥11,952,795.53, mainly due to increased interest expenses[8] - The cash and cash equivalents decreased from ¥1,321,629,847.85 to ¥1,107,878,485.75, a decline of approximately 16.2%[16] - Accounts receivable increased from ¥1,054,710,975.66 to ¥1,681,150,239.74, representing a growth of about 59.1%[16] - Inventory decreased from ¥1,765,389,527.46 to ¥1,698,107,604.76, indicating a slight reduction of approximately 3.8%[16] - Short-term borrowings rose significantly from ¥220,582,163.46 to ¥624,743,963.65, an increase of approximately 183.5%[16] - The company did not conduct an audit for the Q3 2022 report[24]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥2,042,708,210.14, representing a year-on-year increase of 31.43% compared to ¥1,554,260,253.68 in the same period last year[21]. - The net profit attributable to shareholders of the listed company decreased by 20.08% to ¥102,325,135.42 from ¥128,040,074.15 in the previous year[21]. - The net cash flow from operating activities improved significantly, with a net outflow of ¥34,816,026.45, a 91.82% reduction from the previous year's outflow of ¥425,837,790.54[21]. - The total assets of the company increased by 4.86% to ¥6,584,650,496.09 from ¥6,279,256,653.39 at the end of the previous year[21]. - The net assets attributable to shareholders of the listed company rose by 4.26% to ¥2,304,558,059.46 from ¥2,210,298,494.77 at the end of the previous year[21]. - Basic earnings per share decreased by 20.00% to ¥0.24 from ¥0.30 in the same period last year[21]. - The overall gross margin for the reporting period was 21.74%, a decrease of 5.80 percentage points year-on-year[85]. - The net profit attributable to shareholders was 10,232.51 million yuan, down 20.08% year-on-year, mainly due to increased industry competition and changes in customer structure[85]. - The gross profit margin for industrial robots and automation decreased by 3.28% to 28.10%, while the gross profit margin for injection molding machines and supporting equipment increased by 3.33% to 34.77%[115]. Risk Management - The company reported a significant risk from macroeconomic fluctuations and downstream industry cycle changes, which could impact performance[4]. - The management highlighted the risk of raw material shortages and rising procurement costs affecting operational efficiency[4]. - The company is facing challenges related to accounts receivable risks and potential product substitution[4]. - There is a noted risk of talent shortages that could hinder the company's rapid development[4]. - The company emphasizes the importance of addressing technological confidentiality risks in its operations[4]. - The company is addressing supply chain risks due to raw material shortages and rising procurement costs, which have been exacerbated by geopolitical tensions and domestic disruptions[156]. - The company is actively expanding its product lines and enhancing R&D capabilities to mitigate risks associated with technological obsolescence and market competition[159]. Governance and Management - All board members attended the meeting to discuss the report, indicating strong governance practices[4]. - The management has committed to ensuring the accuracy and completeness of the financial report[3]. - The company's management team is young and dynamic, with a strong focus on customer service and a well-structured incentive mechanism to align the interests of shareholders, the company, and employees[108]. - The company has implemented an employee stock option and restricted stock incentive plan, which was approved in February 2019[171]. - The company has established an employee care fund to assist employees facing sudden difficulties[189]. Research and Development - The company has established several key laboratories and research centers in Guangdong Province to support its R&D efforts[29]. - The company has developed a smart energy management system (EMS) and a factory management system (DCS) for large manufacturing enterprises, focusing on energy conservation and emissions reduction[99]. - The company is committed to increasing R&D investment and improving its technological innovation capabilities to maintain market relevance and competitiveness[155]. - The company has achieved breakthroughs in core technologies such as control technology, servo drive technology, and vision systems for industrial robots, with a focus on developing a comprehensive motion control platform[72]. Product Development and Innovation - The company continues to focus on enhancing operational efficiency through its integrated service platform, "Jichengxia," aimed at matching automation needs across various industries[28]. - The company has launched a new SCARA high-speed model TRH002-400-150-A and two new six-axis robots, enhancing speed, precision, and load performance[96]. - The company aims to continue expanding its product lineup and enhancing its automation solutions to meet diverse customer needs[37]. - The company has developed the MBW130 series robotic arm, featuring AI programming and high precision, suitable for injection molding machines under 1000T[40]. - The company emphasizes its core technologies in controllers, servo drives, and vision systems to enhance its smart manufacturing solutions[29]. Market and Sales Strategy - The company achieved a revenue of 204,270.82 million yuan, representing a year-on-year growth of 31.43%[84]. - The automation application system business generated revenue of 36,038.71 million yuan, up 22.84% year-on-year[87]. - The CNC machine tool business saw a significant revenue increase of 734.52%, reaching 9,786.94 million yuan, primarily due to the consolidation of the subsidiary Aifumi's revenue[84]. - The company has a global marketing network with nearly 40 offices and over 400 sales personnel, serving more than 15,000 clients, including major companies like CATL and BYD[110]. - The company plans to leverage its strengths in automation to capture more market share in the coming years[162]. Financial Commitments and Investments - The company plans not to distribute cash dividends, issue bonus shares, or convert capital reserves into share capital for the semi-annual period[169]. - The company has committed to invest RMB 60,917.06 million in Jiangsu Tuosida Robot Co., Ltd., with 47.88% of the investment completed[138]. - The total amount of committed investment projects is RMB 126,433.38 million, with RMB 59,286.91 million utilized by the end of the reporting period[138]. - The company has not changed the use of raised funds, maintaining a 0.00% change in purpose[136]. - The company has reported that all commitments made by major shareholders are being fulfilled as of the report date[192]. Employee and Shareholder Relations - The company has a commitment to not reduce shareholdings for small shareholders, which is being fulfilled as of the report date[195]. - The company has outlined measures for shareholders who fail to comply with their commitments, including extending the lock-up period by 12 months[194]. - The company has completed the lock-up period for shares held by major shareholders, with 100% of the shares released as of the report date[192]. - The employee stock ownership plan involved 320 employees holding a total of 7,383,974 shares, representing 1.73% of the company's total equity[183].